NCT07010380

Brief Summary

This study tests PTFinder, a dual-camera system that makes parathyroid glands glow on screen by capturing their natural near-infrared autofluorescence. After a thyroid or parathyroid operation, the removed tissue is scanned with PTFinder and then checked again under normal white light. We will measure how fast (seconds) and how accurately the device finds real glands, confirmed by frozen pathology or a rapid PTH strip. About 180 adult patients at three Chinese hospitals will join. The imaging adds only a few minutes and does not change any part of the surgery. We will also record blood calcium and PTH at 1 h, 24 h, and 7 d after surgery to see whether better gland recovery lowers low-calcium risk.Collected images will also be used to train and test a deep-learning model for fully automated parathyroid recognition; model performance metrics constitute secondary outcomes.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P50-P75 for all trials

Timeline
45mo left

Started Jun 2025

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress20%
Jun 2025Dec 2029

First Submitted

Initial submission to the registry

June 1, 2025

Completed
Same day until next milestone

Study Start

First participant enrolled

June 1, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 8, 2025

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2029

Last Updated

June 18, 2025

Status Verified

June 1, 2025

Enrollment Period

2.6 years

First QC Date

June 1, 2025

Last Update Submit

June 14, 2025

Conditions

Keywords

Near-Infrared Autofluorescence (NIRAF)Parathyroid IdentificationPTFinder DeviceDual-Channel ImagingRapid PTH Test StripThyroidectomy SpecimenEx-Vivo Fluorescence CameraSensitivity and SpecificityArtificial IntelligenceDeep LearningComputer VisionNIRAF 3 DualPTFinder 3 DualPTFinder 3.0 DualNIRAF 3.0 Dual

Outcome Measures

Primary Outcomes (1)

  • Detection Rate of Pathology-Confirmed Parathyroid Glands per Specimen (PTFinder)

    Proportion of parathyroid glands correctly located by PTFinder divided by the total number of glands confirmed on frozen section or rapid PTH strip. Unit = % (higher = better).

    Intra-operative imaging session (0-5 minutes)

Secondary Outcomes (6)

  • Time to First Parathyroid Gland Identification (PTFinder)

    1 day (Same imaging session)

  • Sensitivity of PTFinder

    1 day (Same imaging session)

  • Specificity of PTFinder

    1 day (Same imaging session)

  • Serum PTH Level

    1 hour , 24 hours, 7 days post-op

  • Corrected Serum Calcium Level

    1 hour , 24 hours, 7 days post-op

  • +1 more secondary outcomes

Study Arms (1)

Surgical Specimen Cohort

Adults (≥18 y) undergoing thyroid or parathyroid surgery; their excised specimens will be imaged ex vivo with the PTFinder device for parathyroid-gland identification.

Device: PTFinder Dual-Channel NIR Autofluorescence Imaging SystemOther: Offline Machine-Learning Algorithm (PTFinder-AI Beta)

Interventions

Ex vivo, non-contact imaging of resected thyroid/parathyroid specimens; captures near-infrared autofluorescence and overlays it on white-light video to highlight parathyroid glands (2-5 min per specimen).

Surgical Specimen Cohort

training/validation on de-identified NIR/RGB frames.

Surgical Specimen Cohort

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Consecutive adult patients undergoing thyroid or parathyroid surgery at three tertiary endocrine-surgery centers in China (Fuzhou, Xiamen, and Wenzhou). Approximately 60 participants will be enrolled per center, for a planned total of 180 surgical specimens. The cohort reflects routine clinical practice and is intended to evaluate the ex-vivo performance of the PTFinder near-infrared autofluorescence imaging device.

You may qualify if:

  • Age ≥18 years.
  • Scheduled for elective total thyroidectomy, hemithyroidectomy, or parathyroidectomy with removal of thyroid/parathyroid tissue.
  • Able and willing to provide written informed consent for participation and specimen imaging.

You may not qualify if:

  • History of neck irradiation or prior neck surgery that may distort parathyroid anatomy.
  • Pregnancy or breastfeeding.
  • Confirmed or suspected parathyroid carcinoma, or thyroid carcinoma requiring en-bloc parathyroid resection.
  • Inability to understand the study procedures or to comply with follow-up.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fujian Medical University Union Hospital

Fuzhou, FJ, 350001, China

RECRUITING

Related Publications (1)

  • Wang B, Zhou CP, Ao W, Cai SJ, Ge ZW, Wang J, Huang WY, Yu JF, Wu SB, Yan SY, Zhang LY, Wang SS, Wang ZH, Hua S, Abdelhamid Ahmed AH, Randolph GW, Zhao WX. Exploring near-infrared autofluorescence properties in parathyroid tissue: an analysis of fresh and paraffin-embedded thyroidectomy specimens. J Biomed Opt. 2025 Jan;30(Suppl 1):S13702. doi: 10.1117/1.JBO.30.S1.S13702. Epub 2024 Jul 18.

    PMID: 39034960BACKGROUND

MeSH Terms

Conditions

Thyroid NeoplasmsHyperparathyroidismHypersensitivity

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsEndocrine System DiseasesThyroid DiseasesParathyroid DiseasesImmune System Diseases

Central Study Contacts

Bo Wang Professor, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
7 Days
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Director, Head of Thyroid Surgery, Principal Investigator, Clinical Professor

Study Record Dates

First Submitted

June 1, 2025

First Posted

June 8, 2025

Study Start

June 1, 2025

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2029

Last Updated

June 18, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will share

De-identified individual-level data-NIR/RGB image files, time-to-detection, pathology confirmation, and postoperative PTH \& calcium values-will be available 6 months after the primary manuscript is published, for 3 years, to qualified researchers who provide a methodologically sound proposal and sign a data-use agreement. Requests should be sent to the Principal Investigator (wangbo@fjmu.edu.cn).

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
"De-identified image dataset and trained AI weights will be deposited in an open repository (e.g., Zenodo) 6 months after publication, pending IRB approval."
Access Criteria
Researchers must obtain IRB approval or exemption and agree to use the data only for scientific purposes.

Locations